Examkin

Question

Difficulty: HardNeoplastic Processes

A 68-year-old man is evaluated for progressive headaches and left-sided weakness over the past month. Magnetic resonance imaging of the brain reveals a 4-cm, ring-enhancing lesion in the right frontal lobe with extensive surrounding edema, characteristic of glioblastoma. The patient undergoes surgical resection. Pathologic examination of the tissue demonstrates pseudo-palisading necrosis and prominent microvascular proliferation. The rapid growth and vascularization of this patient's tumor are primarily driven by a cascade of molecular events initiated by the tumor microenvironment. Arrange the following molecular and cellular events in the correct chronological order to describe the mechanism of tumor-induced angiogenesis in this patient.

  1. 1Localized tissue hypoxia due to tumor expansion beyond the diffusion limit of local capillaries
  2. 2Inhibition of prolyl hydroxylase and subsequent stabilization of hypoxia-inducible factor 1-alpha (HIF-1 α\alpha)
  3. 3Translocation of HIF-1 α\alpha to the nucleus and dimerization with HIF-1 β\beta
  4. 4Binding of the transcription factor complex to hypoxia-response elements and secretion of VEGF
  5. 5Paracrine stimulation of VEGFR-2 on nearby host endothelial cells

Answer

The correct sequence begins with localized hypoxia, which stabilizes HIF-1 α\alpha by inhibiting prolyl hydroxylase. HIF-1 α\alpha then translocates to the nucleus to dimerize with HIF-1 β\beta. This complex induces the transcription and secretion of VEGF, which finally stimulates VEGFR-2 on nearby host endothelial cells to promote angiogenesis.
Tumor angiogenesis is a critical step in neoplastic progression, classically known as the 'angiogenic switch.' In a rapidly growing neoplasm like glioblastoma, cells quickly outgrow their blood supply (typically at a distance >1-2 mm from a capillary). This creates a hypoxic microenvironment. Normally, in the presence of oxygen, prolyl hydroxylase enzymes hydroxylate the HIF-1 α\alpha subunit, targeting it for ubiquitination and proteasomal degradation (often mediated by the von Hippel-Lindau or VHL protein). During hypoxia, prolyl hydroxylase is inactive, allowing HIF-1 α\alpha to stabilize and accumulate. It then translocates to the nucleus, dimerizing with the constitutively expressed HIF-1 β\beta subunit. This active heterodimer binds to hypoxia-response elements (HREs) on the DNA, upregulating the transcription of several pro-angiogenic factors, most notably vascular endothelial growth factor (VEGF). Finally, secreted VEGF acts in a paracrine manner, binding to tyrosine kinase receptors (VEGFR-2) on adjacent host endothelial cells. This stimulates their breakdown of the extracellular matrix, migration, and proliferation to form new capillaries that vascularize the tumor, a process frequently targeted by anti-angiogenic therapies such as bevacizumab.

Step-by-Step Solution

1
Identify the initial trigger for angiogenesis in a rapidly growing solid tumor.
Localized tissue hypoxia occurs because tumor growth outpaces the existing blood supply.
Solid tumors cannot grow beyond 1-2 mm in diameter without initiating their own blood supply, leading to cellular hypoxia in the core.
2
Determine the direct molecular consequence of decreased intracellular oxygen tension.
Prolyl hydroxylase is inhibited, leading to the stabilization and accumulation of HIF-1 α\alpha.
In normoxic conditions, prolyl hydroxylase uses oxygen to tag HIF-1 α\alpha for destruction. Hypoxia halts this process.
3
Trace the intracellular movement of the stabilized protein.
HIF-1 α\alpha translocates to the nucleus and dimerizes with HIF-1 β\beta.
HIF-1 α\alpha must enter the nucleus and find its binding partner to function as a transcription factor.
4
Identify the downstream genetic targets of the transcription factor.
The complex binds to hypoxia-response elements, upregulating VEGF transcription and secretion.
VEGF is the primary pro-angiogenic factor required to signal host tissues.
5
Describe the final paracrine effect of the secreted growth factor.
VEGF stimulates VEGFR-2 on nearby host endothelial cells.
This receptor activation triggers the endothelial cells to proliferate, migrate toward the tumor, and form new vascular networks.

Key Concept

Molecular mechanism of tumor angiogenesis via the HIF-1 α\alpha/VEGF pathway
Rate this question

Topics

Neoplastic Processes

More questions from this topic